AGL
agilon health Inc
NYSE: AGL · HEALTHCARE · MEDICAL CARE FACILITIES
$85.12
-3.76% today
Updated 2026-10-16
Market cap
$1.43B
P/E ratio
—
P/S ratio
0.24x
EPS (TTM)
$-15.41
Dividend yield
—
52W range
$7 – $133
Volume
0.2M
WallStSmart proprietary scores
41
out of 100
Grade: D
Sell
Investment rating
8.7
Growth
A6.0
Quality
B2.5
Profitability
F5.0
Valuation
C+3/9
Piotroski F-Score
Weak
1.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →274 stocks currently score above 75
Price targets
Analyst target
$115.83
+36.08%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy5 Buy9 Hold0 Sell1 Strong Sell
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.15x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z 1.54 — distress zone
- Thin margins at -3.92%
- Negative free cash flow $-60.74M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.39B | $4.32B | $6.06B | $5.93B | $5.92B |
| Net income | $-106.55M | $-262.60M | $-260.15M | $-405.35M | $17.96M |
| EPS | — | — | — | — | $-15.41 |
| Free cash flow | $-163.47M | $-187.01M | $-71.03M | $-119.00M | $-60.74M |
| Profit margin | -4.46% | -6.08% | -4.29% | -6.83% | -3.92% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-01 | ZAMORE, DENISE | Buy | 50,000 | — |
| 2026-04-01 | ZAMORE, DENISE | Sale | 1,024 | $9.75 |
| 2026-04-01 | VENKATACHALIAH, GIRISH | Buy | 28,000 | — |
Peer comparison
Smart narrative
agilon health Inc trades at $85.12. Our Smart Value Score of 41/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 1.54, it sits in the distress. TTM revenue stands at $5.92B. with profit margins at -3.92%.
Frequently asked questions
What is agilon health Inc's stock price?
agilon health Inc (AGL) trades at $85.12, on a P/S of 0.2x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is agilon health Inc overvalued?
agilon health Inc carries a Smart Value Score of 41/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read.
What is the price target of agilon health Inc (AGL)?
The 12-month analyst consensus target is $115.83, about 36.1% above the current $85.12. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is agilon health Inc's revenue?
agilon health Inc's trailing twelve-month revenue is $5.92B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
agilon health Inc's Altman Z-Score is 1.54, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.24x
ROE-205.85%
Beta3.00
50D MA$88.57
200D MA$61.57
Shares out0.02B
Float0.01B
Short ratio—
Avg volume0.2M
Performance
1 week-5.85%
1 month+50.79%
3 months+4197.84%
YTD+3943.85%
1 year—
3 years—
5 years—